In-Home Genetic Tests Represent Risk
By Jesse Reynolds,
Newsday
| 10. 22. 2007
Residents of Long Island and elsewhere in the Northeast will soon see television ads recommending they "Be ready against cancer." One might assume these to be public service announcements calling for more exercise or diets rich in antioxidants. Instead, the ads will promote a test for genes related to breast cancer.
Although this will be the first major direct-to-consumer campaign promoting genetic testing, the manufacturer of the test will not be mentioned. Instead, small text at the bottom of the screens will let viewers know the ad is a "service" of Myriad Genetics, which holds patents on the tested genes.
Myriad's test is likely to be the tip of the iceberg, and what it suggests for the future is quite alarming. We'll soon see more advertising campaigns that, like those of drugs, prey on our insecurities and fears. And unlike Myriad's test, which must be ordered through your doctor, an increasing number of these will be available over the counter and performed in the privacy - and isolation - of your own home.
This trend highlights three troubling aspects of...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Lauren Hammer Breslow and Vanessa Smith, Bill of Health | 01.28.2026
On Jan. 24, 2026, the New York Times reported that DNA sequences contributed by children and families to support a federal effort to understand adolescent brain development were later co-opted by other researchers and used to publish “race science”...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...